Pharmacokinetics and Safety of Single Oral Doses of Emtricitabine in Human Immunodeficiency Virus-Infected Children

Emtricitabine (FTC; Emtriva), a potent deoxycytidine nucleoside reverse transcriptase inhibitor, has recently been approved by the U.S. Food and Drug Administration for the treatment of human immunodeficiency virus (HIV) infection. In adults, FTC has demonstrated linear kinetics over a wide dose ran...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Antimicrob Agents Chemother
Autors principals: Wang, Laurene H., Wiznia, Andrew A., Rathore, Mobeen H., Chittick, Gregory E., Bakshi, Saroj S., Emmanuel, Patricia J., Flynn, Patricia M.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology (ASM) 2004
Matèries:
Antiviral Agents
Accés en línia:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC310155/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/14693538/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.48.1.183-191.2004
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars